# Inhibikase Therapeutics, Inc.: Form DEF 14A, filed May 12, 2025

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: DEF 14A
- Filed: 2025-05-12
- Accepted by EDGAR: May 12, 2025, 20:05 ET
- Period: 2025-06-27
- Accession: 0000950170-25-069152
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000095017025069152/ikt-proxy-def-annual-jun.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000095017025069152/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000095017025069152/ikt-proxy-def-annual-jun.htm

Filed May 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-069152. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.